Corient Private Wealth LLC Trims Position in UnitedHealth Group Incorporated (NYSE:UNH)

Corient Private Wealth LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,150,702 shares of the healthcare conglomerate’s stock after selling 70,352 shares during the quarter. UnitedHealth Group accounts for about 1.0% of Corient Private Wealth LLC’s portfolio, making the stock its 16th largest holding. Corient Private Wealth LLC owned about 0.13% of UnitedHealth Group worth $580,435,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. Promus Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $32,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $37,000. Finally, Pillar Financial Advisors LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on UNH. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Stephens lifted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Finally, Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Stock Up 1.5 %

Shares of UNH opened at $488.52 on Friday. The firm has a market cap of $446.85 billion, a P/E ratio of 31.52, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company’s 50-day moving average price is $511.36 and its 200 day moving average price is $550.07. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the company posted $5.83 EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.72%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.